A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00391729 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
221
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott